Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Immune Design CS (IMDZ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Civitas, Entegra, and Immune Design on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Civitas Solutions, Inc., Entegra Financial Corp., and Immune Design Corp. Additional...

CIVI : 17.76 (+0.11%)
ENFC : 22.22 (-5.25%)
IMDZ : 5.85 (+0.17%)
IMMUNE DESIGN CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

Rigrodsky & Long, P.A.:

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

ELLI : 98.55 (-0.14%)
MXWL : 4.51 (-1.53%)
CASM : 2.44 (+0.83%)
IMDZ : 5.85 (+0.17%)
STI : 57.40 (-4.60%)
ULTI : 330.17 (-0.23%)
LABL : 49.86 (-0.04%)
Merck Begins Tender Offer to Acquire Immune Design

Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of...

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Acquisition

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

ELLI : 98.55 (-0.14%)
MXWL : 4.51 (-1.53%)
CASM : 2.44 (+0.83%)
IMDZ : 5.85 (+0.17%)
STI : 57.40 (-4.60%)
ULTI : 330.17 (-0.23%)
LABL : 49.86 (-0.04%)
The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie

The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
ABBV : 79.76 (-1.82%)
RHHBY : 33.7600 (-1.06%)
Merck to Buy Immunotherapy Developer Immune Design for $300M

Merck (MRK) plans to acquire Immune Design for $300 million in cash. Merck will pay $5.85 in cash for each share of Immune Design.

MRK : 82.29 (-0.80%)
LLY : 128.30 (-0.01%)
IMDZ : 5.85 (+0.17%)
BMY : 48.16 (-1.55%)
Thinking about buying stock in Apple, Canopy Growth Corp, Immune Design, Roku Inc or Zosano Pharma?

InvestorsObserver issues critical PriceWatch Alerts for AAPL, CGC, IMDZ, ROKU, and ZSAN.

ROKU : 63.91 (-4.53%)
AAPL : 191.05 (-2.07%)
IMDZ : 5.85 (+0.17%)
ZSAN : 5.09 (-4.86%)
Pharma Stock Roundup: MRK Buys IMDZ, FDA Grants Priority Review to Some Candidates

Merck (MRK) to buy Immune Design for $300 million. FDA grants priority review to regulatory applications filed by Merck, Roche (RHHBY) and AbbVie (ABBV).

NVO : 50.72 (-2.78%)
MRK : 82.29 (-0.80%)
LLY : 128.30 (-0.01%)
IMDZ : 5.85 (+0.17%)
ABBV : 79.76 (-1.82%)
RHHBY : 33.7600 (-1.06%)
PFE : 41.85 (-1.18%)
IMMUNE DESIGN CORP. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

Rigrodsky & Long, P.A.:

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Immune Design Corp.

Rowley Law PLLC is investigating potential claims against Immune Design Corp. (NASDAQ: IMDZ) and its board of directors for breach of fiduciary duty concerning the proposed acquisition of the company by...

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
SHAREHOLDER ALERT: WeissLaw LLP Investigates Immune Design Corp.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Immune Design Corp. ("IMDZ" or the "Company") (NASDAQ: IMDZ) in connection with...

IMDZ : 5.85 (+0.17%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Immune Design Corp. to Merck & Co., Inc. for $5.85 Per Share is Fair to Shareholders

The following statement is being issued by Levi & Korsinsky, LLP:

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
Merck to Acquire Immune Design

Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Immune Design (NASDAQ:IMDZ), today announced that the companies have entered into a definitive agreement under which...

MRK : 82.29 (-0.80%)
IMDZ : 5.85 (+0.17%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 9.51 (-2.36%)
EPAY : 48.33 (-4.88%)
EXAS : 89.00 (-3.28%)
WYNN : 116.91 (-3.49%)
HMSY : 30.88 (-6.11%)
GLT : 13.31 (-4.79%)
MHK : 124.86 (-2.56%)
BBW : 5.55 (+0.18%)
CDW : 95.87 (-2.75%)
COUP : 90.40 (-8.95%)
QTWO : 68.44 (-3.32%)
DENN : 17.84 (+0.11%)
MYL : 28.69 (-1.91%)
DFRG : 6.50 (-0.46%)
GCAP : 6.40 (-2.88%)
FEYE : 16.67 (-4.03%)
MXIM : 54.21 (-1.90%)
POL : 28.60 (-6.14%)
AN : 33.57 (-3.20%)
TWO : 13.80 (-0.93%)
HUBG : 39.74 (-3.57%)
AR : 8.39 (-4.00%)
RE : 214.99 (-0.23%)
NNBR : 7.65 (-4.02%)
ARE : 141.72 (-0.51%)
CVI : 40.68 (-2.87%)
CERS : 6.16 (-4.64%)
NDAQ : 83.89 (-0.55%)
ELLI : 98.55 (-0.14%)
BLDR : 12.55 (-4.85%)
EGRX : 47.15 (-6.85%)
RGLD : 92.06 (-0.20%)
PRGO : 47.25 (-2.74%)
PENN : 20.19 (-4.04%)
NTAP : 66.84 (-3.84%)
IBM : 139.45 (-1.41%)
NTRI : 42.89 (-0.05%)
BANR : 51.97 (-3.04%)
CWT : 53.73 (-1.56%)
STAA : 37.67 (-4.39%)
ATHN : 134.99 (+0.01%)
CL : 66.00 (+0.26%)
TFSL : 15.96 (-2.27%)
UFPI : 29.22 (-5.28%)
SDRL : 9.21 (-9.26%)
GOV : 6.87 (-5.50%)
HQY : 73.78 (-10.82%)
IPGP : 144.77 (-5.43%)
MINI : 33.08 (-4.59%)
CMTL : 21.17 (-4.68%)
CHD : 67.10 (+0.49%)
GPI : 60.34 (-4.24%)
HRL : 43.59 (+1.11%)
RARE : 64.65 (-6.36%)
MLI : 30.71 (-4.54%)
GPS : 24.52 (-2.39%)
CHS : 4.23 (-5.37%)
RYAM : 12.67 (-6.98%)
PBI : 6.34 (-6.21%)
NUVA : 56.00 (-1.20%)
IMDZ : 5.85 (+0.17%)
CAMP : 12.24 (-4.00%)
NOC : 268.36 (-1.51%)
AEL : 26.77 (-6.30%)
EBIX : 47.92 (-5.59%)
DISCA : 26.67 (-0.04%)
GPOR : 7.63 (-3.42%)
BGS : 24.64 (-0.44%)
TECH : 192.34 (-4.04%)
PCH : 36.36 (-2.83%)
NOV : 26.63 (-4.55%)
TECD : 98.45 (-5.97%)
DISCK : 25.45 (+0.04%)
DECK : 140.51 (-3.90%)
NOW : 241.21 (-3.88%)
MGLN : 64.63 (-2.30%)
IEX : 147.93 (-2.45%)
PTC : 93.12 (-1.94%)
AVT : 42.12 (-4.45%)
RGS : 18.26 (-2.56%)
BSFT : 54.95 (+0.09%)
FOSL : 13.88 (-4.74%)
WAL : 39.07 (-5.40%)
IVR : 16.09 (-0.80%)
ENR : 45.09 (-2.28%)
ISBC : 11.45 (-3.13%)
SHOO : 32.17 (-3.36%)
HDP : 14.68 (+1.80%)
AWK : 106.78 (+0.53%)
OMED : 0.88 (-2.02%)
LADR : 16.73 (-1.36%)
BIG : 35.05 (-0.57%)
WY : 25.76 (-1.64%)
JBLU : 15.93 (-2.27%)
GNMK : 7.30 (-2.67%)
FORM : 15.77 (-3.67%)
PFSI : 21.11 (-3.25%)
NEWM : 11.47 (-3.45%)
KFRC : 34.20 (-4.92%)
HOLX : 46.85 (-1.82%)
TMK : 80.31 (-2.50%)
AXTA : 24.88 (-3.72%)
PGEM : 21.65 (unch)
CLH : 70.31 (-1.65%)
CLI : 21.87 (-2.28%)
NRG : 42.49 (-2.03%)
CLGX : 35.94 (-1.07%)
SFLY : 39.32 (-3.46%)
ICUI : 229.27 (-2.97%)
CARA : 18.30 (-6.82%)
WTR : 37.12 (+0.65%)
NTGR : 33.71 (-3.91%)
OLED : 154.31 (-4.52%)
VNDA : 17.59 (-4.61%)
HIBB : 21.70 (+20.29%)
FFBC : 23.02 (-4.92%)
DLTR : 101.43 (+0.02%)
EQT : 19.51 (-3.70%)
OMER : 16.89 (-4.68%)
KTOS : 15.63 (-3.16%)
SRCL : 50.49 (+0.68%)
GES : 18.37 (-4.87%)
KMX : 61.63 (-1.09%)
PLAB : 9.09 (-3.71%)
NCS : 6.05 (-6.20%)
MAR : 124.50 (-0.45%)
MRVL : 19.71 (-5.19%)
UAL : 79.63 (-1.69%)
CNK : 39.84 (-0.10%)
NATH : 69.11 (-2.41%)
TPH : 12.38 (-0.64%)
OCUL : 3.94 (-5.29%)
SKYW : 51.60 (-2.66%)
HIVE : 4.42 (-4.12%)
GAIA : 9.24 (-1.60%)
ESRX : 92.33 (-3.62%)
PHM : 26.58 (+1.06%)
EBS : 48.33 (-1.37%)
CACI : 180.27 (-2.96%)
SAVE : 53.05 (-1.74%)
EZPW : 9.11 (-4.11%)
TPX : 55.17 (-4.19%)
KLAC : 120.53 (-2.64%)
ULTA : 330.52 (-1.38%)
WWE : 86.71 (-5.87%)
ESV : 4.23 (-4.30%)
LTRPA : 13.93 (-4.33%)
DAL : 49.76 (-1.07%)
BMY : 48.16 (-1.55%)
ECL : 173.38 (-1.39%)
CHRW : 84.68 (-2.98%)
WWW : 34.62 (-3.73%)
ETH : 18.55 (-3.08%)
IART : 55.29 (-3.56%)
LE : 15.83 (-1.80%)
LH : 154.32 (-1.27%)
HZO : 18.07 (-3.93%)
MTD : 702.07 (-3.79%)
OSTK : 18.41 (-5.59%)
LDOS : 62.99 (-1.19%)
SAGE : 156.72 (-0.80%)
CIEN : 37.06 (-3.82%)
MTW : 16.30 (-4.73%)
AMC : 15.06 (-2.33%)
NDLS : 6.61 (-2.22%)
EFII : 26.00 (-5.90%)
SIVB : 212.19 (-7.06%)
MU : 41.62 (-5.39%)
DSW : 20.32 (-3.61%)
VRNT : 50.95 (-3.76%)
OII : 15.56 (-7.49%)
SAFM : 127.26 (-0.24%)
DATA : 127.85 (-6.43%)
TLYS : 11.00 (-5.42%)
TREE : 330.64 (-3.16%)
TRUP : 29.72 (-6.36%)
AMCX : 56.32 (-2.00%)
EXPD : 74.12 (-2.33%)
SUPN : 35.66 (-5.64%)
NBIX : 85.11 (-5.25%)
SAIC : 70.99 (-2.50%)
CBM : 38.19 (-2.73%)
BURL : 145.99 (-2.03%)
AMED : 122.60 (-2.92%)
EXPR : 3.93 (-4.61%)
SBH : 17.59 (-0.51%)
ATSG : 21.16 (-3.11%)
PLT : 47.43 (-7.65%)
QDEL : 63.72 (-5.93%)
NLNK : 1.91 (-7.73%)
STMP : 82.71 (-3.99%)
IPCC : 142.80 (+0.32%)
BMTC : 34.51 (-5.37%)
STML : 12.37 (-6.71%)
EGL : 29.10 (+0.24%)
LUV : 49.32 (-2.80%)
CCL : 56.42 (-1.47%)
INOV : 12.26 (-2.62%)
COTY : 11.22 (-0.53%)
MGM : 26.09 (-3.01%)
AKBA : 8.39 (-3.56%)
LGIH : 58.19 (+3.67%)
CDNS : 61.76 (-2.09%)
CRZO : 12.19 (-7.72%)
TEN : 22.55 (-7.96%)
HAIN : 23.29 (+0.22%)
Why Is Immune Design (IMDZ) Up 15.8% Since Last Earnings Report?

Immune Design (IMDZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

IMDZ : 5.85 (+0.17%)
Detailed Research: Economic Perspectives on NanoString Technologies, Tyson Foods, Welbilt, Immune Design, Turning Point Brands, and LGI Homes -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NanoString Technologies, Inc....

TPB : 44.71 (-5.07%)
WBT : 15.70 (-3.80%)
IMDZ : 5.85 (+0.17%)
LGIH : 58.19 (+3.67%)
NSTG : 23.44 (-3.26%)
TSN : 66.61 (+0.14%)
Immune Design Reports Increased Overall Response Rate and Longer Progression Free Survival of Patients with Follicular Lymphoma Treated in a Randomized Trial with a Combination Regimen of G100 and Pembrolizumab

-- Overall Response Rate (ORR) of 46% in Patients Receiving the Combination

IMDZ : 5.85 (+0.17%)
Immune Design to Present at Piper Jaffray 30th Annual Healthcare Conference

Immune Design (Nasdaq: IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that management will present at the Piper Jaffray 30 Annual Healthcare Conference...

IMDZ : 5.85 (+0.17%)
Immune Design (IMDZ) Posts Narrower-Than-Expected Loss in Q1

Immune Design (IMDZ) posts narrower-than-expected loss and misses revenue estimates in Q1. The company remains on track to start a pivotal phase III study for CMB305 on patients with synovial sarcoma.

PTGX : 13.74 (+3.31%)
LGND : 124.86 (-3.34%)
IMDZ : 5.85 (+0.17%)
SNY : 44.26 (-2.58%)

Van Meerten Stock Picks

Trilogy Metals - Pick of the Day
My Stock Pick of the Day belongs metal mining company Trilogy Metals(TMQ).
TMQ -0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar